You are here: Home » Companies » Start-ups » News

India Life Sciences Fund invests $6.2 million in Oasis

Funding to be used to open 20 more clinics in Bengaluru, Chennai and other cities during next five years

Oasis Centre for Reproductive Medicine, a Hyderabad-based in-vitro fertilisation (IVF) chain of clinics, said on Monday that it has raised $6.2 million (Rs 40 crore) from II.

Founded in 2009 by infertility specialist Durga G Rao and entrepreneur Kiran Gadela, Oasis currently operates three centres in Hyderabad and one in Vijayawada. The promoters plan to use the funding to open 20 more clinics in Bengaluru, Chennai and other cities during the next five years.

Healthcare-focused had made significant investments in other Indian pharma and healthcare players, including Hyderabad-based Gland Pharma in the past. For Oasis this is the first investment from outside.

"Since inception, Oasis' key focus has been to establish a center of excellence with transparent, ethical and evidence-based practice to treat infertility. backing us is further testimony to the quality of service we provide at Oasis. The investment would be used for starting 20 more centers in the next five years, with the primary focus on expansion in South India," Kiran Gadela, co-founder and managing director at Oasis.

The market is predicted to grow at a CAGR of 10.1 per cent in the next five years to reach little over Rs 5,000 crore by 2021, with infertility being a huge unmet need, according to Anula K Jayasuria, managing director, InvAscent, the investment advisor to EILSF (fund) and II. Jayasuria has joined the board of Oasis.

"Oasis, which has a strong focus on research, will also create extensive training programmes, in both clinical and embryology services. We have developed world-class systems, processes and protocols and ourr multi-disciplinary teams work diligently to implement them. This is reflected in our excellent results," said Oasis cofounder Durga G Rao.

Bengaluru-based has been the financial advisors for this transaction.

image
Business Standard
177 22
Business Standard

India Life Sciences Fund invests $6.2 million in Oasis

Funding to be used to open 20 more clinics in Bengaluru, Chennai and other cities during next five years

BS Reporter  |  Hyderabad 

India Life Sciences Fund invests $6.2 million in Oasis

Oasis Centre for Reproductive Medicine, a Hyderabad-based in-vitro fertilisation (IVF) chain of clinics, said on Monday that it has raised $6.2 million (Rs 40 crore) from II.

Founded in 2009 by infertility specialist Durga G Rao and entrepreneur Kiran Gadela, Oasis currently operates three centres in Hyderabad and one in Vijayawada. The promoters plan to use the funding to open 20 more clinics in Bengaluru, Chennai and other cities during the next five years.

Healthcare-focused had made significant investments in other Indian pharma and healthcare players, including Hyderabad-based Gland Pharma in the past. For Oasis this is the first investment from outside.

"Since inception, Oasis' key focus has been to establish a center of excellence with transparent, ethical and evidence-based practice to treat infertility. backing us is further testimony to the quality of service we provide at Oasis. The investment would be used for starting 20 more centers in the next five years, with the primary focus on expansion in South India," Kiran Gadela, co-founder and managing director at Oasis.

The market is predicted to grow at a CAGR of 10.1 per cent in the next five years to reach little over Rs 5,000 crore by 2021, with infertility being a huge unmet need, according to Anula K Jayasuria, managing director, InvAscent, the investment advisor to EILSF (fund) and II. Jayasuria has joined the board of Oasis.

"Oasis, which has a strong focus on research, will also create extensive training programmes, in both clinical and embryology services. We have developed world-class systems, processes and protocols and ourr multi-disciplinary teams work diligently to implement them. This is reflected in our excellent results," said Oasis cofounder Durga G Rao.

Bengaluru-based has been the financial advisors for this transaction.

RECOMMENDED FOR YOU

India Life Sciences Fund invests $6.2 million in Oasis

Funding to be used to open 20 more clinics in Bengaluru, Chennai and other cities during next five years

Funding to be used to open 20 more clinics in Bengaluru, Chennai and other cities during next five years Oasis Centre for Reproductive Medicine, a Hyderabad-based in-vitro fertilisation (IVF) chain of clinics, said on Monday that it has raised $6.2 million (Rs 40 crore) from II.

Founded in 2009 by infertility specialist Durga G Rao and entrepreneur Kiran Gadela, Oasis currently operates three centres in Hyderabad and one in Vijayawada. The promoters plan to use the funding to open 20 more clinics in Bengaluru, Chennai and other cities during the next five years.

Healthcare-focused had made significant investments in other Indian pharma and healthcare players, including Hyderabad-based Gland Pharma in the past. For Oasis this is the first investment from outside.

"Since inception, Oasis' key focus has been to establish a center of excellence with transparent, ethical and evidence-based practice to treat infertility. backing us is further testimony to the quality of service we provide at Oasis. The investment would be used for starting 20 more centers in the next five years, with the primary focus on expansion in South India," Kiran Gadela, co-founder and managing director at Oasis.

The market is predicted to grow at a CAGR of 10.1 per cent in the next five years to reach little over Rs 5,000 crore by 2021, with infertility being a huge unmet need, according to Anula K Jayasuria, managing director, InvAscent, the investment advisor to EILSF (fund) and II. Jayasuria has joined the board of Oasis.

"Oasis, which has a strong focus on research, will also create extensive training programmes, in both clinical and embryology services. We have developed world-class systems, processes and protocols and ourr multi-disciplinary teams work diligently to implement them. This is reflected in our excellent results," said Oasis cofounder Durga G Rao.

Bengaluru-based has been the financial advisors for this transaction.

image
Business Standard
177 22

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard